Summary
- Current Price
- As of today, XAGE price is $0.28, down -3.45% in the most recent trading session on
- Current Price All-Time High
- XAGE price is currently -99.93% below its historical high of $399.30 set on
- Market Cap
- XAGE current market cap is $499K, down -93.07% year-over-year
- PE Ratio
- XAGE PE ratio is unknown
- Revenue
- XAGE current annual revenue is $50.30K, up +100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for XAGE has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Longevity Health Holdings, Inc. |
| Ticker | NASDAQ: XAGE |
| Exchange | NASDAQ |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | carmellcosmetics.com |
| Employees | 13 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.28 | |
| Price, 1D Change | -3.45% | |
| Market Cap | $499K | |
| - | ||
| PE Ratio | - | |
| Beta | 21.41 | |
| Revenue | $50K | |
| Revenue, 1Y Change | +100.00% | |
| EPS | -$16.57 | |
| EPS, 1Y Change | -1,033.16% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:30 | |
| Next Split | N/A | N/A |
| Last Ticker Change | CTCX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$16.57 | |
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| Revenue | $50.30K | |
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $0.28 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
No EPS data available
Revenue
No revenue data available
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -96.09% | |
| Price, 3Y | -99.91% | |
| Market Cap, 1Y | -93.07% | |
| Market Cap, 3Y | -99.69% | |
| Revenue, 1Y | +100.00% | |
| Revenue, 3Y | +100.00% | |
| EPS, 1Y | -1,033.16% | |
| EPS, 3Y | -151,961.47% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.28 | |
| SMA 200 | $1.56 | |
| SMA 200 vs Price | +456.00% | |
| SMA 50 | $0.34 | |
| SMA 50 vs Price | +22.54% | |
| Beta | 21.41 | |
| ATR | $0.02 | |
| 14-Day RSI | 42.16 | |
| 10-Day Volatility | 51.75% | |
| 1-Year Volatility | 2,411.74% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $50.30K | |
| EPS | -$16.57 | |
| Gross Profit | -$153.30K | |
| Gross Margin | -304.77% | |
| Operating Profit | -$5.00M | |
| Operating Margin | -9,937.38% | |
| Net Income | -$10.65M | |
| Net Margin | -21.17% | |
| EBITDA | -$10.50M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | -0.14 | |
| Current Ratio | 0.15 | |
| Quick Ratio | 0.14 | |
| Interest Coverage | -218.34 | |
| F-Score | 5 | |
| Altman Z-Score | -93.36 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 0.34 | |
| PB Ratio | -0.13 | |
| EV/EBITDA | 0.00 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | -$4.71M | |
| Cash & Equivalents | $157.10K | |
| Total Assets | $1.47M | |
| Current Assets | $955.60K | |
| Total Liabilities | $6.19M | |
| Current Liabilities | $5.88M | |
| Total Debt | $639.00K | |
| Short Term Debt | $329.10K | |
| Accounts Payable | $4.06M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $5.05M | |
| Operating Expenses | $5.04M | |
| Cost Of Goods Sold | $203.60K | |
| SG&A | $3.90M | |
| D&A | $197.30K | |
| Interest Expense | $49.00K | |
| Income Tax | -$97.30K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$4.39M | |
| CFI | -$748.80K | |
| CFF | $2.38M | |
| Capex | $0.00 | |
| Free Cash Flow | -$4.39M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| No data | N/A | N/A |
Analyst sentiment
Institutional ownership
Screeners with XAGE
FAQ
What is the ticker symbol for Longevity Health Holdings, Inc.?
The ticker symbol for Longevity Health Holdings, Inc. is NASDAQ:XAGE
Does Longevity Health Holdings, Inc. pay dividends?
No, Longevity Health Holdings, Inc. does not pay dividends
What sector is Longevity Health Holdings, Inc. in?
Longevity Health Holdings, Inc. is in the Consumer Defensive sector
What industry is Longevity Health Holdings, Inc. in?
Longevity Health Holdings, Inc. is in the Household & Personal Products industry
What country is Longevity Health Holdings, Inc. based in?
Longevity Health Holdings, Inc. is headquartered in United States
When did Longevity Health Holdings, Inc. go public?
Longevity Health Holdings, Inc. initial public offering (IPO) was on September 23, 2021
Is Longevity Health Holdings, Inc. in the S&P 500?
No, Longevity Health Holdings, Inc. is not included in the S&P 500 index
Is Longevity Health Holdings, Inc. in the NASDAQ 100?
No, Longevity Health Holdings, Inc. is not included in the NASDAQ 100 index
Is Longevity Health Holdings, Inc. in the Dow Jones?
No, Longevity Health Holdings, Inc. is not included in the Dow Jones index
When was Longevity Health Holdings, Inc. last earnings report?
Longevity Health Holdings, Inc.'s most recent earnings report was on November 14, 2025
When does Longevity Health Holdings, Inc. report earnings?
The date for Longevity Health Holdings, Inc.'s next earnings report has not been announced yet
Data Sources & References
- XAGE Official Website www.carmellcosmetics.com
- XAGE Profile on Yahoo Finance finance.yahoo.com/quote/XAGE
- XAGE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/xage